Intranasal gene therapy to prevent infection by SARS-CoV-2 variants.
SARS-CoV-2 variants have emerged with enhanced pathogenicity and transmissibility, and escape from pre-existing immunity, suggesting first-generation vaccines and monoclonal antibodies may now be less effective. Here we present an approach for preventing clinical sequelae and the spread of SARS-CoV-...
Saved in:
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/1456eae8f81744b0b130542e55e5bbc3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!